Population-specific positive selection on low CR1 expression in malaria-endemic regions

PLoS One. 2023 Jan 10;18(1):e0280282. doi: 10.1371/journal.pone.0280282. eCollection 2023.

Abstract

Complement Receptor Type 1 (CR1) is a malaria-associated gene that encodes a transmembrane receptor of erythrocytes and is crucial for malaria parasite invasion. The expression of CR1 contributes to the rosetting of erythrocytes in the brain bloodstream, causing cerebral malaria, the most severe form of the disease. Here, we study the history of adaptation against malaria by analyzing selection signals in the CR1 gene. We used whole-genome sequencing datasets of 907 healthy individuals from malaria-endemic and non-endemic populations. We detected robust positive selection in populations from the hyperendemic regions of East India and Papua New Guinea. Importantly, we identified a new adaptive variant, rs12034598, which is associated with a slower rate of erythrocyte sedimentation and is linked with a variant associated with low levels of CR1 expression. The combination of the variants likely drives natural selection. In addition, we identified a variant rs3886100 under positive selection in West Africans, which is also related to a low level of CR1 expression in the brain. Our study shows the fine-resolution history of positive selection in the CR1 gene and suggests a population-specific history of CR1 adaptation to malaria. Notably, our novel approach using population genomic analyses allows the identification of protective variants that reduce the risk of malaria infection without the need for patient samples or malaria individual medical records. Our findings contribute to understanding of human adaptation against cerebral malaria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Erythrocytes
  • Genetics, Population
  • Humans
  • India
  • Malaria, Cerebral* / genetics
  • Malaria, Cerebral* / metabolism
  • Papua New Guinea
  • Receptors, Complement 3b* / genetics
  • Selection, Genetic

Substances

  • CR1 protein, human
  • Receptors, Complement 3b

Grants and funding

This research was supported by the Singapore Ministry of Education, Academic Research Fund Tier 1 (grant number 2017-T1-001-046 and grant number RG100/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.